TYRA
TYRA
NASDAQ · Biotechnology

Tyra Biosciences Inc

$36.32
-0.21 (-0.56%)
As of Mar 24, 10:02 PM ET ·
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Buy 17 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target -48.4% upside
Low Target $15.89
Average Target $18.74
High Target $31.24
Current Price $36.32
Current
$36.32
Target
$18.74
$15.89 $18.74 avg $31.24
Scenario Analysis
Bear Case
$15.89
-56.2%
Low target
Base Case
$18.74
-48.4%
Avg target
Bull Case
$31.24
+-14.0%
High target
Risk/Reward
0.2x
Unfavorable
Price in Context
52-Week High
$33.99
6.8% from high
52-Week Low
$6.42
+465.7% from low
Target vs 52W High
$18.74
-44.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -27.6%